Novo Nordisk

PRnewswire | January 20, 2017

Stock-Callers.com today evaluates the following Drug Manufacturers equities: Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), Novo Nordisk A/S (NYSE: NVO), Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). These stocks belong to the Healthcare sector which fell on Thursday, January 19th, 2017, finishing near its session lows. As per a NASDAQ report, the NYSE Health Care Index dropped over 0.7%, while shares of health care companies in the S&P 500 also ...

Novo Nordisk | June 07, 2017

The European Commission has now approved the drug’s use for prophylaxis, on-demand treatment of bleeding and surgical procedures in adults and adolescents with the condition....

Novo Nordisk | September 29, 2017

To mark World Heart Day today, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigating the level of CVD awareness and knowledge among people living with type 2 diabetes. The global survey - Taking Diabetes to Heart - is available in multiple languages until March 2018, and people with type 2 diabetes are encouraged to participate....

Novo Nordisk | December 06, 2017

Today the International Diabetes Federation (IDF) presented the interim results of the first ever multi-country online survey on CVD risk awareness and knowledge among people living with type 2 diabetes, indicating low levels of awareness and limited dialogue between patients and healthcare professionals. The global survey - Taking Diabetes to Heart - developed in partnership with Novo Nordisk, runs until March 2018 and is open to all people with type 2 diabetes....